Display options
Cite
Radke S, Volman I, Mehta P, et al. Testosterone biases the amygdala toward social threat approach. Sci Adv. 2015;1(5):e1400074doi: 10.1126/sciadv.1400074.
Radke, S., Volman, I., Mehta, P., van Son, V., Enter, D., Sanfey, A., Toni, I., de Bruijn, E. R., & Roelofs, K. (2015). Testosterone biases the amygdala toward social threat approach. Science advances, 1(5), e1400074. https://doi.org/10.1126/sciadv.1400074
Radke, Sina, et al. "Testosterone biases the amygdala toward social threat approach." Science advances vol. 1,5 (2015): e1400074. doi: https://doi.org/10.1126/sciadv.1400074
Radke S, Volman I, Mehta P, van Son V, Enter D, Sanfey A, Toni I, de Bruijn ER, Roelofs K. Testosterone biases the amygdala toward social threat approach. Sci Adv. 2015 Jun 12;1(5):e1400074. doi: 10.1126/sciadv.1400074. eCollection 2015 Jun. PMID: 26601187; PMCID: PMC4640609.
Copy Download .nbib Format: NLM
Share it on

Sci Adv. 2015 Jun 12;1(5):e1400074. doi: 10.1126/sciadv.1400074. eCollection 2015 Jun.

Testosterone biases the amygdala toward social threat approach.

Science advances

Sina Radke, Inge Volman, Pranjal Mehta, Veerle van Son, Dorien Enter, Alan Sanfey, Ivan Toni, Ellen R A de Bruijn, Karin Roelofs

Affiliations

  1. Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, 6500 GL Nijmegen, Netherlands. ; Department of Psychiatry, Psychotherapy and Psychosomatics, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany. ; Jülich Aachen Research Alliance (JARA)-Translational Brain Medicine, 52428/52074 Jülich/Aachen, Germany.
  2. Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, 6500 GL Nijmegen, Netherlands. ; Behavioural Science Institute, Radboud University Nijmegen, 6500 HE Nijmegen, Netherlands. ; Sobell Department for Motor Neuroscience and Movement Disorders, University College London, London WC1N 3BG, UK.
  3. Department of Psychology, University of Oregon, Eugene, OR 97403, USA.
  4. Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, 6500 GL Nijmegen, Netherlands.
  5. Behavioural Science Institute, Radboud University Nijmegen, 6500 HE Nijmegen, Netherlands. ; Department of Clinical Psychology and Leiden Institute for Brain and Cognition, Leiden University, 2333 AK Leiden, Netherlands.
  6. Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, 6500 GL Nijmegen, Netherlands. ; Behavioural Science Institute, Radboud University Nijmegen, 6500 HE Nijmegen, Netherlands.
  7. Department of Clinical Psychology and Leiden Institute for Brain and Cognition, Leiden University, 2333 AK Leiden, Netherlands.

PMID: 26601187 PMCID: PMC4640609 DOI: 10.1126/sciadv.1400074

Abstract

Testosterone enhances amygdala reactions to social threat, but it remains unclear whether this neuroendocrine mechanism is relevant for understanding its dominance-enhancing properties; namely, whether testosterone biases the human amygdala toward threat approach. This pharmacological functional magnetic-resonance imaging study shows that testosterone administration increases amygdala responses in healthy women during threat approach and decreases it during threat avoidance. These findings support and extend motivational salience models by offering a neuroendocrine mechanism of motivation-specific amygdala tuning.

Keywords: amygdala; approach-avoidance; motivational salience; social approach; testosterone

References

  1. Hum Brain Mapp. 1997;5(2):133-6 - PubMed
  2. Psychiatry Res. 2012 Dec 30;200(2-3):761-6 - PubMed
  3. Biol Psychol. 2007 Oct;76(3):135-46 - PubMed
  4. Magn Reson Med. 2006 Jun;55(6):1227-35 - PubMed
  5. Arch Gen Psychiatry. 2000 Feb;57(2):149-53; discussion 155-6 - PubMed
  6. Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):9991-5 - PubMed
  7. Cereb Cortex. 2011 Oct;21(10):2282-90 - PubMed
  8. Anat Embryol (Berl). 2005 Dec;210(5-6):343-52 - PubMed
  9. Neuroscience. 2015 Feb 12;286:171-86 - PubMed
  10. Biol Psychiatry. 2006 May 1;59(9):872-4 - PubMed
  11. Neuroimage. 2010 Aug 1;52(1):277-83 - PubMed
  12. Neuropsychopharmacology. 2009 Feb;34(3):539-47 - PubMed
  13. Biol Psychiatry. 2014 Aug 15;76(4):324-31 - PubMed
  14. Psychoneuroendocrinology. 2006 Aug;31(7):859-66 - PubMed
  15. Behav Res Ther. 2010 Apr;48(4):290-4 - PubMed
  16. Neuroimage. 2012 Jul 2;61(3):730-7 - PubMed
  17. Biol Psychiatry. 2008 Feb 1;63(3):263-70 - PubMed
  18. J Neurosci. 2013 May 22;33(21):8974-9 - PubMed
  19. Curr Biol. 2011 Oct 25;21(20):1766-70 - PubMed
  20. Psychoneuroendocrinology. 2010 Jan;35(1):114-21 - PubMed
  21. J Psychosom Res. 2012 Mar;72(3):205-13 - PubMed
  22. Biol Psychiatry. 2009 Feb 15;65(4):336-43 - PubMed
  23. Psychoneuroendocrinology. 2013 Jun;38(6):808-17 - PubMed
  24. Neuroimage. 2005 May 1;25(4):1325-35 - PubMed
  25. Nature. 2012 May 23;485(7399):E4-5; discussion E5-6 - PubMed
  26. Psychol Sci. 2013 Nov 1;24(11):2306-14 - PubMed
  27. Soc Cogn Affect Neurosci. 2009 Mar;4(1):50-8 - PubMed
  28. Neuroimage. 2005 Jul 1;26(3):839-51 - PubMed
  29. Neuropsychologia. 2010 Oct;48(12):3399-404 - PubMed
  30. Psychoneuroendocrinology. 2012 Jun;37(6):773-81 - PubMed
  31. Psychol Sci. 2012 May 1;23(5):459-63 - PubMed
  32. Neuroimage. 2005 Jul 1;26(3):960-4 - PubMed
  33. Front Psychol. 2014 May 08;5:378 - PubMed
  34. Psychol Sci. 2008 Feb;19(2):152-60 - PubMed
  35. Horm Behav. 2014 Apr;65(4):351-4 - PubMed

Publication Types